scispace - formally typeset
P

Patrizia Burra

Researcher at University of Padua

Publications -  402
Citations -  13192

Patrizia Burra is an academic researcher from University of Padua. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 53, co-authored 305 publications receiving 10648 citations. Previous affiliations of Patrizia Burra include Katholieke Universiteit Leuven & Royal Free Hospital.

Papers
More filters
Journal ArticleDOI

EASL Clinical Practice Guidelines: Liver transplantation

TL;DR: This Clinical Practice Guideline has been developed to assist physicians and other healthcare providers during the evaluation process of candidates for LT and to help them in the correct management of patients after LT.
Journal ArticleDOI

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

TL;DR: There is a significant contribution to liver cirrhosis in humans from extrahepatically derived myofibroblasts in liver disease of diverse etiology.
Journal ArticleDOI

Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness

TL;DR: When TACE is not totally effective, it may induce a significant neoangiogenetic reaction, as suggested by an increase in VEGF and b-FGF following treatment; this affects patient survival and antiangiogenic drugs may be indicated in TACE-treated HCC.
Journal ArticleDOI

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

TL;DR: Findings suggest that hepatitis C virus-related liver damage is characterized by increased iron storage (possibly induced by the virus) which elicits a free-radical-mediated peroxidation, with consequent steatosis and activation of glutathione turnover, probably in response to free- radical-mediated liver damage.
Journal ArticleDOI

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

TL;DR: In this article, the prognosis and risk factors for morbidity and mortality in liver transplantation for hepatitis C virus (HCV)-related liver disease are determined. But, the results of transplantation are compromised by a significant risk of cirrhosis, although 5-year survival is satisfactory.